1. The Subretinal Fluid Tolerance Post Faricimab Injection Short Case Review Study

    The Subretinal Fluid Tolerance Post Faricimab Injection Short Case Review Study

    Aim: To evaluate the efficacy of a new Anti-VEGF molecules Faricimab 6 mg (0.05ml of 120mg/ml) in resolving a refractory subretinal fluid (SRF) in wet AMD cases. Method: we retrospectively reviewed a 64-year-old female Caucasian single eye patient, presented to our clinic on September 2019 with (wet AMD) in the right eye & advanced wet AMD with fibrosis and scar in the left eye. the patient decided to treat the right eye only, she received initially 3 loading doses of aflibercept (40 mg/ml) and then was shifted to a treat and extend regimen (T&E). Thew best corrected ...

    Read Full Article

    Login to comment.

  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Authors